It’s been nearly a year since a CNV vaccination program went live in Oregon.
Now, a report says the vaccine is getting into more than half the country, and that some states are using them to vaccinate their residents at a rate much faster than anyone thought possible.
That’s bad news for people living in the areas where the CVD vaccine is already going into use.
The report from researchers at the Oregon Health Authority found that more than 2.3 million Americans are now on the vaccination rolls, more than twice the number who got the shot in the state a year ago.
That means the state is at about 50 percent of the U.S. population, according to the Oregonian.
The number of people who are vaccinated has jumped from a few hundred in 2015 to about 1.2 million today.
Oregon is one of the states that has made the most progress, according the study.
Its health department is now using the vaccine in about 2.5 percent of its population.
But the number of residents in that state who are now vaccinated is about 30 percent higher than it was in 2015, when Oregon was already one of its most vaccinated states.
This may be because of the outbreak of the virus in the U, which has brought the spread of the vaccine closer to the states.
“Our ability to deploy and deliver vaccines is very limited,” said Chris Chilton, the director of the Oregon Department of Health Services.
“We have a large and dedicated team working to deliver the CVA vaccines to our residents.”
So far, the vaccine has been deployed in only nine counties in Oregon, according Chilton.
But a small number of counties that haven’t seen the vaccine rollout yet have had the vaccine deployed at a much higher rate than the rest of the state.
Chilton says it’s also likely because some counties are getting the vaccine sooner, while others have been waiting for a longer period.
Chardon says the number one thing that makes it so difficult for a state like Oregon to deploy vaccines is that many counties have their own systems to do the testing.
But he says the problem is compounded by the fact that some counties have no access to testing facilities and can’t get their own equipment to test.
“It’s the infrastructure, the data, and the coordination, that makes things so difficult,” Chardon said.
“You need a lot of infrastructure, and you need a very strong coordination system, and it’s difficult to get that right.”
The CVA vaccine is being used to vaccine people in at least half of the United States, the study found.
But just how much the vaccine will be used is unclear.
The U.N. says it has no estimate of how many people will be vaccinated.
The researchers used data from a statewide CVA vaccination database that the Oregon health department started using last year.
The database covers all people who received the vaccine, including those who were already vaccinated, but doesn’t include people who were never vaccinated.
Oregon officials say they’re using this data to track how quickly the vaccine spreads, but they don’t yet know how many residents are on the program and how many have received the shot.
Chatonn said he thinks it’s possible the program could reach about half of Oregon’s population in about a year.
“I don’t think that’s unrealistic at all,” Chatonnn said.